3D ultrasound scan to guide treatment decisions in liver cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether a special 3D ultrasound scan (using contrast) can help support decisions for people with colorectal cancer that has spread to the liver. If you have planned new cancer treatment, the scan may add information to help doctors guide care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver metastases from colorectal low-grade adenocarcinoma, confirmed by biopsy or typical scan findings, and you are starting a new cancer treatment.
- You are 18 years or older.
- You have at least one liver spot to measure at least 1 cm but no bigger than 14 cm that can be seen with ultrasound.
- You can follow study instructions and are willing to have the ultrasound exams.
- You can consent in writing (or have a legal representative if you cannot consent yourself).
- You are not pregnant and not breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging technique that uses a special dye combined with a chemotherapy drug to help surgeons see and remove liver cancer more precisely during surgery. It is for people with a first-time, single liver tumor that is small and can be surgically removed.
This study is testing a new way to use ultrasound to help treat colorectal cancer that has spread to the liver. It may help doctors see how tumors respond to treatment.
This trial tests a new imaging system to help surgeons plan liver removal operations. If you have a liver tumor that can be removed, this study may help improve surgical accuracy and outcomes.
This study tests a new ultrasound technique to see if it can predict early how well your cancer treatment will work on liver tumors that started in the colon or rectum. It uses special sound waves to measure pressure inside the tumor, which might help doctors adjust treatment sooner.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
This trial tests a new combination of treatments for colorectal cancer that has spread to the liver. It combines a special type of radiation therapy (called PULSAR) with immunotherapy and chemotherapy plus a drug that targets blood vessels, to see if it helps shrink tumors and improve outcomes.
Hear when a new Liver Cancer, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.